Myocarditis associated with COVID-19 vaccination
- PMID: 38942751
- PMCID: PMC11213864
- DOI: 10.1038/s41541-024-00893-1
Myocarditis associated with COVID-19 vaccination
Abstract
Following the start of the COVID-19 vaccination campaign, the adverse events of myocarditis and pericarditis were linked mainly to mRNA COVID-19 vaccines by the regulatory authorities worldwide. COVID-19 vaccines have been administered to several million people and the risk of myocarditis post COVID-19 vaccination has been characterised in great detail. At the present time the research data available are scarce and there is still no clear understanding of the biological mechanism/s responsible for this disease. This manuscript provides a concise overview of the epidemiology of myocarditis and the most prominent mechanistic insights in the pathophysiology of the disease. Most importantly it underscores the needed next steps in the research agenda required to characterize the pathophysiology of this disease post-COVID-19 vaccination. Finally, it shares our perspectives and considerations for public health.
© 2024. European Medicines Agency.
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study.Int Immunopharmacol. 2024 May 30;133:112022. doi: 10.1016/j.intimp.2024.112022. Epub 2024 Apr 13. Int Immunopharmacol. 2024. PMID: 38615382
-
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand.Vaccines (Basel). 2023 Mar 28;11(4):749. doi: 10.3390/vaccines11040749. Vaccines (Basel). 2023. PMID: 37112661 Free PMC article.
-
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445. BMJ. 2022. PMID: 35830976 Free PMC article. Review.
-
Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system.Front Immunol. 2022 Sep 12;13:938322. doi: 10.3389/fimmu.2022.938322. eCollection 2022. Front Immunol. 2022. PMID: 36172346 Free PMC article.
-
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature.BMJ Open. 2022 May 25;12(5):e059223. doi: 10.1136/bmjopen-2021-059223. BMJ Open. 2022. PMID: 35613761 Free PMC article.
Cited by
-
Current update on the neurological manifestations of long COVID: more questions than answers.EXCLI J. 2024 Nov 27;23:1463-1486. doi: 10.17179/excli2024-7885. eCollection 2024. EXCLI J. 2024. PMID: 39850323 Free PMC article. Review.
-
A Narrative Overview of Fatal Myocarditis in Infant with Focus on Sudden Unexpected Death and Forensic Implications.J Clin Med. 2025 Jun 18;14(12):4340. doi: 10.3390/jcm14124340. J Clin Med. 2025. PMID: 40566082 Free PMC article. Review.
-
Perioperative cardiovascular risk and preventions of patients with post-COVID-19 condition.Heliyon. 2024 Oct 15;10(20):e39345. doi: 10.1016/j.heliyon.2024.e39345. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39640715 Free PMC article. Review.
-
mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases.Vaccines (Basel). 2024 Dec 16;12(12):1418. doi: 10.3390/vaccines12121418. Vaccines (Basel). 2024. PMID: 39772079 Free PMC article. Review.
-
Chest Pain With Significantly Elevated Troponins: Be Wary of False Positives.Cureus. 2025 Jan 6;17(1):e77018. doi: 10.7759/cureus.77018. eCollection 2025 Jan. Cureus. 2025. PMID: 39777375 Free PMC article.
References
-
- EMA. Nuvaxovid: EPAR- Public assessment report. https://www.ema.europa.eu/documents/product-information/nuvaxovid-epar-p....
Publication types
LinkOut - more resources
Full Text Sources